Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Dried blood spots can be as stable as frozen liquid samples for storing certain metabolites.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Glycyrrhizic acid may help reduce unwanted hair growth.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The system improved diabetic wound healing in rats.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

GD-23 reduces anxiety by relying on neurosteroid production.